RAN and cancer: The top eight pathways selected for the EGFR mutation samples include salivary secretion, RAN degradation, ECM‐receptor interaction, cancer miRNAs, measles, glycerophospholipid metabolism, MAPK pathway, and focal adhesion (Figure 6C).